# Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.

> **NCT05401032** · PHASE2 · RECRUITING · sponsor: **Clinical Academic Center (2CA-Braga)** · enrollment: 70 (estimated)

## Conditions studied

- BPH
- LUTS(Lower Urinary Tract Symptoms)

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** 5-hidroxitriptophan

## Key facts

- **NCT ID:** NCT05401032
- **Lead sponsor:** Clinical Academic Center (2CA-Braga)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05401032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05401032, "Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05401032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*